According to the National Cancer Institute, there will be 233,000 new cases of prostate cancer diagnosed in the U.S. in 2014, along with 32,050 deathsRead More
Recent research suggests that some men who receive a prostate cancer diagnosis may be seeking out treatment options that are more aggressive than what they actually need.
Prostate cancer has become more treatable in recent years due to advances in medical technology. However, the American Cancer Society reports that in 2010, there will be more than 200,000 new cases diagnosed, along with more than 32,000 deaths.Read More
The Federal Drug Administration approved Provenge, the first prostate cancer treatment vaccine of its kind.
The vaccine does not prevent nor cure prostate cancer, but helps men with advanced prostate cancer live four months longer, reports the newspaper. More than 32 percent of men given Provenge were alive after 3 years of beginning the treatment, as opposed to 23 percent who were given the placebo, Kantoff told the newspaper. According to the American Cancer Society, 192,000 men were diagnosed with prostate cancer in 2009 and 27,000 did not survive.Read More